ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
hsa05205,Proteoglycans in cancer,42/253,204/8535,2.76E-24,6.87E-22,2.73E-22,TP53/PIK3CA/ERBB2/ACTB/CDKN1A/RHOA/HRAS/AKT1/KRAS/ERBB3/FN1/DDX5/FLNA/CDC42/SOS1/SRC/ACTG1/EGFR/MTOR/HSPG2/PLCG1/PTK2/ANK2/PIK3R1/ANK3/CTNNB1/GRB2/STAT3/IQGAP1/MET/MAPK1/ESR1/ANK1/RAF1/MDM2/IGF1R/CBL/ITGAV/BRAF/KDR/ERBB4/PTCH1,42
hsa05225,Hepatocellular carcinoma,38/253,170/8535,2.24E-23,2.79E-21,1.11E-21,TP53/PIK3CA/ARID1A/ACTB/CDKN1A/APC/HRAS/RB1/AKT1/KRAS/CDKN2A/SMARCA4/PTEN/SOS1/ACTG1/EGFR/MTOR/SMAD4/PLCG1/PIK3R1/NFE2L2/CTNNB1/GRB2/TGFBR2/MET/ARID2/CSNK1A1/MAPK1/SMARCC2/RAF1/CDK6/SMARCA2/IGF1R/BRAF/SMAD3/CDK4/ARID1B/TGFBR1,38
hsa01522,Endocrine resistance,29/253,99/8535,1.38E-21,1.15E-19,4.56E-20,TP53/PIK3CA/ERBB2/CDKN1A/HRAS/RB1/JUN/AKT1/NCOR1/KRAS/CDKN2A/SOS1/SRC/EGFR/MTOR/PTK2/PIK3R1/MED1/GRB2/MAPK1/ESR1/NOTCH1/NCOA3/RAF1/MDM2/IGF1R/BRAF/CDK4/NOTCH3,29
hsa05220,Chronic myeloid leukemia,26/253,77/8535,3.14E-21,1.95E-19,7.77E-20,TP53/PIK3CA/CDKN1A/HDAC1/HRAS/RB1/AKT1/KRAS/ABL1/CDKN2A/SOS1/SMAD4/PIK3R1/IKBKB/GRB2/TGFBR2/MAPK1/RAF1/NFKBIA/MDM2/CDK6/CBL/BRAF/SMAD3/CDK4/TGFBR1,26
hsa05215,Prostate cancer,28/253,98/8535,1.52E-20,7.58E-19,3.01E-19,TP53/EP300/CREBBP/PIK3CA/ERBB2/CDKN1A/HRAS/RB1/HSP90AB1/AKT1/KRAS/HSP90AA1/PTEN/SOS1/EGFR/MTOR/PIK3R1/IKBKB/AR/CTNNB1/GRB2/MAPK1/PDGFRA/RAF1/NFKBIA/MDM2/IGF1R/BRAF,28
hsa04919,Thyroid hormone signaling pathway,30/253,122/8535,7.04E-20,2.92E-18,1.16E-18,TP53/EP300/CREBBP/PIK3CA/ACTB/HDAC1/HRAS/RXRA/AKT1/NCOR1/KRAS/MED12/SRC/ACTG1/MTOR/PLCG1/PIK3R1/MED1/CTNNB1/MED13/MAPK1/ESR1/NOTCH1/NCOA3/RAF1/MDM2/SIN3A/ITGAV/TSC2/NOTCH3,30
hsa01521,EGFR tyrosine kinase inhibitor resistance,25/253,80/8535,1.65E-19,5.86E-18,2.33E-18,PIK3CA/ERBB2/FGFR3/HRAS/AKT1/KRAS/ERBB3/PTEN/SOS1/SRC/EGFR/MTOR/PLCG1/PIK3R1/NF1/GRB2/STAT3/MET/MAPK1/PDGFRA/RAF1/JAK2/IGF1R/BRAF/KDR,25
hsa05212,Pancreatic cancer,24/253,77/8535,9.68E-19,3.01E-17,1.20E-17,TP53/PIK3CA/ERBB2/CDKN1A/RB1/AKT1/KRAS/CDKN2A/BRCA2/CDC42/EGFR/MTOR/SMAD4/PIK3R1/IKBKB/TGFBR2/STAT3/MAPK1/RAF1/CDK6/BRAF/SMAD3/CDK4/TGFBR1,24
hsa05210,Colorectal cancer,25/253,87/8535,1.63E-18,4.50E-17,1.79E-17,TP53/PIK3CA/CDKN1A/APC/RHOA/HRAS/JUN/AKT1/KRAS/SOS1/EGFR/MTOR/SMAD4/PIK3R1/DCC/CTNNB1/MSH2/GRB2/TGFBR2/MLH1/MAPK1/RAF1/BRAF/SMAD3/TGFBR1,25
hsa05224,Breast cancer,31/253,148/8535,2.55E-18,6.35E-17,2.52E-17,TP53/PIK3CA/ERBB2/CDKN1A/APC/BRCA1/HRAS/RB1/JUN/AKT1/KRAS/BRCA2/PTEN/SOS1/EGFR/MTOR/PIK3R1/KIT/CTNNB1/GRB2/CSNK1A1/MAPK1/ESR1/NOTCH1/NCOA3/RAF1/CDK6/IGF1R/BRAF/CDK4/NOTCH3,31
hsa05214,Glioma,23/253,76/8535,1.11E-17,2.52E-16,1.00E-16,TP53/PIK3CA/CDKN1A/HRAS/RB1/AKT1/KRAS/CDKN2A/PTEN/SOS1/EGFR/MTOR/PLCG1/PIK3R1/GRB2/MAPK1/PDGFRA/RAF1/MDM2/CDK6/IGF1R/BRAF/CDK4,23
hsa05165,Human papillomavirus infection,44/253,333/8535,1.80E-17,3.73E-16,1.48E-16,TP53/EP300/CREBBP/PIK3CA/ATM/CDKN1A/APC/HDAC1/HRAS/RB1/AKT1/TSC1/KRAS/FN1/ATR/CHD4/PTEN/CDC42/SOS1/EGFR/MTOR/PTK2/PIK3R1/IKBKB/CTNNB1/PPP2R1A/GRB2/UBR4/CASP8/CSNK1A1/MAPK1/NOTCH1/RAF1/MDM2/CDK6/HLA-B/PARD3/ITGAV/TBK1/CDK4/LAMA4/TSC2/NOTCH3/COL6A3,44
hsa05161,Hepatitis B,31/253,163/8535,4.81E-17,9.22E-16,3.66E-16,TP53/EP300/CREBBP/PIK3CA/CDKN1A/HRAS/RB1/JUN/AKT1/KRAS/SOS1/SRC/SMAD4/HSPG2/MAP3K1/PIK3R1/IKBKB/GRB2/TGFBR2/CASP8/STAT3/MAPK1/RAF1/NFKBIA/JAK2/DDX3X/YWHAZ/BRAF/SMAD3/TBK1/TGFBR1,31
hsa05223,Non-small cell lung cancer,22/253,73/8535,6.47E-17,1.15E-15,4.58E-16,TP53/PIK3CA/ERBB2/CDKN1A/HRAS/RB1/RXRA/AKT1/KRAS/CDKN2A/SOS1/EGFR/PLCG1/PIK3R1/GRB2/STAT3/MET/MAPK1/RAF1/CDK6/BRAF/CDK4,22
hsa04068,FoxO signaling pathway,28/253,133/8535,1.07E-16,1.77E-15,7.05E-16,EP300/CREBBP/PIK3CA/ATM/CDKN1A/HRAS/AKT1/KRAS/PTEN/PLK1/SOS1/EGFR/SMAD4/PIK3R1/IKBKB/GRB2/CSNK1E/TGFBR2/USP7/STAT3/INSR/MAPK1/RAF1/MDM2/IGF1R/BRAF/SMAD3/TGFBR1,28
hsa04520,Adherens junction,24/253,93/8535,1.26E-16,1.97E-15,7.82E-16,EP300/CREBBP/ERBB2/ACTB/RHOA/CDC42/CSNK2A1/FYN/SRC/ACTG1/EGFR/SMAD4/CTNNB1/TGFBR2/IQGAP1/MET/INSR/MAPK1/PARD3/IGF1R/CDH1/SMAD3/CTNND1/TGFBR1,24
hsa04151,PI3K-Akt signaling pathway,44/253,362/8535,4.38E-16,6.42E-15,2.55E-15,TP53/PIK3CA/ERBB2/CDKN1A/FGFR3/BRCA1/HRAS/RXRA/HSP90AB1/AKT1/TSC1/KRAS/ERBB3/FN1/SYK/HSP90AA1/PTEN/SOS1/EGFR/MTOR/PTK2/PIK3R1/IKBKB/KIT/PPP2R1A/GRB2/EPHA2/MET/INSR/MAPK1/PDGFRA/RAF1/JAK2/MDM2/CDK6/IGF1R/YWHAZ/ITGAV/CDK4/KDR/ERBB4/LAMA4/TSC2/COL6A3,44
hsa05218,Melanoma,21/253,73/8535,9.76E-16,1.35E-14,5.37E-15,TP53/PIK3CA/CDKN1A/HRAS/RB1/AKT1/KRAS/CDKN2A/PTEN/EGFR/PIK3R1/MET/MAPK1/PDGFRA/RAF1/MDM2/CDK6/IGF1R/CDH1/BRAF/CDK4,21
hsa04110,Cell cycle,29/253,158/8535,1.43E-15,1.87E-14,7.42E-15,TP53/EP300/CREBBP/ATM/CDKN1A/STAG2/CUL1/HDAC1/SMC1A/RB1/PRKDC/ABL1/CDKN2A/ATR/PLK1/RAD21/MCM7/SMAD4/SMC3/PPP2R1A/NDC80/MDM2/CDK6/ATRX/YWHAZ/PDS5B/SMAD3/CDK4/CDC27,29
hsa05213,Endometrial cancer,19/253,59/8535,2.29E-15,2.85E-14,1.13E-14,TP53/PIK3CA/ERBB2/CDKN1A/APC/HRAS/AKT1/KRAS/PTEN/SOS1/EGFR/PIK3R1/CTNNB1/GRB2/MLH1/MAPK1/RAF1/CDH1/BRAF,19
hsa04012,ErbB signaling pathway,22/253,86/8535,3.04E-15,3.61E-14,1.43E-14,PIK3CA/ERBB2/CDKN1A/HRAS/JUN/AKT1/KRAS/ERBB3/ABL1/SOS1/SRC/EGFR/MTOR/PLCG1/PTK2/PIK3R1/GRB2/MAPK1/RAF1/CBL/BRAF/ERBB4,22
hsa05203,Viral carcinogenesis,32/253,205/8535,5.64E-15,6.39E-14,2.54E-14,TP53/EP300/CREBBP/PIK3CA/CDKN1A/RHOA/HDAC1/HRAS/RB1/JUN/KRAS/CDKN2A/CHD4/SYK/CDC42/SRC/PIK3R1/GRB2/UBR4/USP7/CASP8/STAT3/MAPK1/NFKBIA/MDM2/HNRNPK/CDK6/HLA-B/DDX3X/YWHAZ/CDK4/C3,32
hsa05206,MicroRNAs in cancer,39/253,312/8535,9.96E-15,1.08E-13,4.29E-14,TP53/EP300/CREBBP/PIK3CA/ERBB2/ATM/CDKN1A/APC/RHOA/FGFR3/HDAC1/BRCA1/HRAS/KRAS/ERBB3/ABL1/CDKN2A/PTEN/SOS1/EGFR/MTOR/PLCG1/PIK3R1/IKBKB/GRB2/TP63/STAT3/MET/MAPK1/NOTCH1/PDGFRA/RAF1/MDM2/DNMT1/HNRNPK/CDK6/EZH2/DICER1/NOTCH3,39
hsa05219,Bladder cancer,16/253,41/8535,1.18E-14,1.22E-13,4.86E-14,TP53/ERBB2/CDKN1A/FGFR3/HRAS/RB1/KRAS/CDKN2A/SRC/EGFR/MAPK1/RAF1/MDM2/CDH1/BRAF/CDK4,16
hsa05226,Gastric cancer,27/253,150/8535,2.39E-14,2.38E-13,9.44E-14,TP53/PIK3CA/ERBB2/CDKN1A/APC/HRAS/RB1/RXRA/AKT1/KRAS/SOS1/EGFR/MTOR/SMAD4/PIK3R1/CTNNB1/GRB2/TGFBR2/MLH1/MET/CSNK1A1/MAPK1/RAF1/CDH1/BRAF/SMAD3/TGFBR1,27
hsa04510,Focal adhesion,31/253,203/8535,2.89E-14,2.77E-13,1.10E-13,PIK3CA/ERBB2/ACTB/RHOA/HRAS/JUN/AKT1/FN1/FLNA/PTEN/CDC42/SOS1/FYN/SRC/ACTG1/EGFR/PTK2/PIK3R1/CTNNB1/GRB2/MET/MAPK1/FLNB/PDGFRA/RAF1/IGF1R/ITGAV/BRAF/KDR/LAMA4/COL6A3,31
hsa05163,Human cytomegalovirus infection,32/253,226/8535,9.52E-14,8.78E-13,3.49E-13,TP53/PIK3CA/CDKN1A/RHOA/HRAS/RB1/AKT1/TSC1/KRAS/CDKN2A/SOS1/SRC/EGFR/MTOR/PTK2/PIK3R1/IKBKB/CTNNB1/GRB2/CASP8/STAT3/MAPK1/PDGFRA/RAF1/NFKBIA/MDM2/CDK6/HLA-B/ITGAV/TBK1/CDK4/TSC2,32
hsa04218,Cellular senescence,26/253,157/8535,5.71E-13,5.08E-12,2.02E-12,TP53/PIK3CA/ATM/CDKN1A/HRAS/RB1/AKT1/TSC1/KRAS/CDKN2A/ATR/PTEN/MTOR/PIK3R1/TGFBR2/MAPK1/RAF1/MDM2/CDK6/HLA-B/ZFP36L1/SMAD3/CDK4/FOXM1/TSC2/TGFBR1,26
hsa04010,MAPK signaling pathway,35/253,300/8535,2.10E-12,1.80E-11,7.17E-12,TP53/ERBB2/FGFR3/HRAS/JUN/AKT1/KRAS/ERBB3/FLNA/CDC42/HSPA8/SOS1/EGFR/MAP3K1/IKBKB/CACNA1A/KIT/NF1/GRB2/EPHA2/TGFBR2/MET/INSR/MAPK1/PDGFRA/RAF1/IGF1R/RASA1/MAP3K5/HSPA1L/BRAF/KDR/ERBB4/TGFBR1/DAXX,35
hsa05167,Kaposi sarcoma-associated herpesvirus infection,28/253,196/8535,3.01E-12,2.50E-11,9.92E-12,TP53/EP300/CREBBP/PIK3CA/CDKN1A/HRAS/RB1/JUN/AKT1/KRAS/SYK/SRC/MTOR/PLCG1/PIK3R1/IKBKB/CTNNB1/CASP8/STAT3/MAPK1/RAF1/NFKBIA/JAK2/CDK6/HLA-B/TBK1/CDK4/C3,28
hsa05160,Hepatitis C,25/253,159/8535,5.42E-12,4.35E-11,1.73E-11,TP53/PIK3CA/CDKN1A/HRAS/RB1/RXRA/AKT1/KRAS/SOS1/EGFR/PIK3R1/IKBKB/CTNNB1/PPP2R1A/GRB2/CASP8/STAT3/MAPK1/RAF1/NFKBIA/CDK6/YWHAZ/BRAF/TBK1/CDK4,25
hsa05211,Renal cell carcinoma,17/253,70/8535,1.19E-11,9.28E-11,3.69E-11,EP300/CREBBP/PIK3CA/CDKN1A/HRAS/JUN/AKT1/KRAS/CDC42/SOS1/PIK3R1/GRB2/MET/MAPK1/RAF1/BRAF/ARNT,17
hsa05166,Human T-cell leukemia virus 1 infection,29/253,224/8535,1.47E-11,1.11E-10,4.42E-11,TP53/EP300/CREBBP/PIK3CA/ATM/CDKN1A/HRAS/RB1/JUN/AKT1/KRAS/CDKN2A/ATR/TRRAP/PTEN/SMAD4/MAP3K1/PIK3R1/IKBKB/TGFBR2/LCK/CANX/MAPK1/NFKBIA/HLA-B/SMAD3/CDK4/CDC27/TGFBR1,29
hsa05417,Lipid and atherosclerosis,28/253,216/8535,3.29E-11,2.41E-10,9.58E-11,TP53/PIK3CA/RHOA/HRAS/RXRA/HSP90AB1/JUN/AKT1/KRAS/APOB/HSP90AA1/CDC42/HSPA8/SRC/PPARG/PLCG1/PTK2/PIK3R1/NFE2L2/IKBKB/CASP8/STAT3/MAPK1/NFKBIA/JAK2/MAP3K5/HSPA1L/TBK1,28
hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,18/253,90/8535,9.61E-11,6.84E-10,2.72E-10,PIK3CA/HRAS/JUN/AKT1/KRAS/PTEN/CSNK2A1/EGFR/MTOR/PLCG1/PIK3R1/IKBKB/STAT3/LCK/MAPK1/RAF1/NFKBIA/JAK2,18
hsa04015,Rap1 signaling pathway,27/253,212/8535,1.14E-10,7.91E-10,3.14E-10,PIK3CA/ACTB/RHOA/FGFR3/HRAS/AKT1/KRAS/CDC42/SRC/ACTG1/EGFR/PLCG1/PIK3R1/KIT/CTNNB1/EPHA2/MET/INSR/MAPK1/PDGFRA/RAF1/PARD3/IGF1R/CDH1/BRAF/KDR/CTNND1,27
hsa05230,Central carbon metabolism in cancer,16/253,71/8535,1.65E-10,1.11E-09,4.42E-10,TP53/PIK3CA/ERBB2/FGFR3/HRAS/AKT1/KRAS/PTEN/EGFR/MTOR/PIK3R1/KIT/MET/MAPK1/PDGFRA/RAF1,16
hsa04722,Neurotrophin signaling pathway,20/253,120/8535,2.71E-10,1.78E-09,7.06E-10,TP53/PIK3CA/RHOA/HRAS/JUN/AKT1/KRAS/ABL1/CDC42/SOS1/MAP3K1/PLCG1/PIK3R1/IKBKB/GRB2/MAPK1/RAF1/NFKBIA/MAP3K5/BRAF,20
hsa04660,T cell receptor signaling pathway,20/253,122/8535,3.68E-10,2.35E-09,9.34E-10,PIK3CA/RHOA/HRAS/JUN/AKT1/KRAS/CDC42/SOS1/FYN/PLCG1/PIK3R1/IKBKB/PPP2R1A/GRB2/LCK/MAPK1/PTPRC/RAF1/NFKBIA/CDK4,20
hsa05221,Acute myeloid leukemia,15/253,68/8535,8.64E-10,5.38E-09,2.14E-09,PIK3CA/HRAS/AKT1/KRAS/SOS1/MTOR/PIK3R1/IKBKB/KIT/GRB2/STAT3/PML/MAPK1/RAF1/BRAF,15
hsa04072,Phospholipase D signaling pathway,21/253,149/8535,2.33E-09,1.41E-08,5.62E-09,PIK3CA/RHOA/HRAS/AKT1/TSC1/KRAS/SYK/SOS1/FYN/EGFR/MTOR/PLCG1/PIK3R1/KIT/GRB2/INSR/MAPK1/PDGFRA/RAF1/DNM2/TSC2,21
hsa04210,Apoptosis,20/253,136/8535,2.67E-09,1.58E-08,6.28E-09,TP53/SPTAN1/PIK3CA/ATM/ACTB/HRAS/JUN/AKT1/KRAS/ACTG1/PIK3R1/IKBKB/CASP8/MAPK1/RAF1/NFKBIA/MAP3K5/PARP1/LMNA/DAXX,20
hsa01524,Platinum drug resistance,15/253,75/8535,3.69E-09,2.14E-08,8.49E-09,TP53/PIK3CA/ERBB2/ATM/CDKN1A/BRCA1/AKT1/CDKN2A/PIK3R1/MSH2/CASP8/MLH1/MAPK1/MDM2/MAP3K5,15
hsa04933,AGE-RAGE signaling pathway in diabetic complications,17/253,101/8535,5.32E-09,2.99E-08,1.19E-08,PIK3CA/HRAS/JUN/AKT1/KRAS/FN1/CDC42/SMAD4/PLCG1/PIK3R1/TGFBR2/STAT3/MAPK1/JAK2/SMAD3/CDK4/TGFBR1,17
hsa05216,Thyroid cancer,11/253,37/8535,5.40E-09,2.99E-08,1.19E-08,TP53/CDKN1A/HRAS/RXRA/KRAS/TPR/PPARG/CTNNB1/MAPK1/CDH1/BRAF,11
hsa05100,Bacterial invasion of epithelial cells,15/253,78/8535,6.52E-09,3.53E-08,1.40E-08,PIK3CA/ACTB/RHOA/CLTC/FN1/CDC42/SRC/ACTG1/PTK2/PIK3R1/CTNNB1/MET/DNM2/CBL/CDH1,15
hsa04014,Ras signaling pathway,26/253,238/8535,7.31E-09,3.88E-08,1.54E-08,PIK3CA/RHOA/FGFR3/HRAS/AKT1/KRAS/ABL1/CDC42/SOS1/EGFR/PLCG1/PIK3R1/IKBKB/KIT/NF1/GRB2/EPHA2/MET/INSR/MAPK1/PDGFRA/RAF1/IGF1R/RASA1/TBK1/KDR,26
hsa05222,Small cell lung cancer,16/253,93/8535,1.10E-08,5.68E-08,2.26E-08,TP53/PIK3CA/CDKN1A/RB1/RXRA/AKT1/FN1/PTEN/PTK2/PIK3R1/IKBKB/NFKBIA/CDK6/ITGAV/CDK4/LAMA4,16
hsa05207,Chemical carcinogenesis - receptor activation,24/253,215/8535,1.88E-08,9.54E-08,3.79E-08,PIK3CA/HRAS/RB1/RXRA/HSP90AB1/JUN/AKT1/KRAS/HSP90AA1/SOS1/SRC/EGFR/MTOR/PIK3R1/CACNA1A/AR/GRB2/KPNB1/STAT3/MAPK1/ESR1/RAF1/JAK2/ARNT,24
hsa05231,Choline metabolism in cancer,16/253,99/8535,2.77E-08,1.38E-07,5.49E-08,PIK3CA/HRAS/JUN/AKT1/TSC1/KRAS/SOS1/EGFR/MTOR/PLCG1/PIK3R1/GRB2/MAPK1/PDGFRA/RAF1/TSC2,16
hsa05169,Epstein-Barr virus infection,23/253,204/8535,3.13E-08,1.53E-07,6.07E-08,TP53/PIK3CA/CDKN1A/HDAC1/RB1/JUN/AKT1/SYK/PIK3R1/IKBKB/USP7/CASP8/STAT3/NCOR2/NFKBIA/MDM2/CDK6/HLA-B/SIN3A/PSMC3/TBK1/PSMD2/CDK4,23
hsa04810,Regulation of actin cytoskeleton,24/253,232/8535,8.23E-08,3.94E-07,1.57E-07,PIK3CA/ACTB/APC/RHOA/FGFR3/HRAS/AKT1/KRAS/FN1/MYH9/CDC42/SOS1/SRC/ACTG1/EGFR/PTK2/PIK3R1/IQGAP1/MAPK1/PDGFRA/RAF1/MYH10/ITGAV/BRAF,24
hsa04935,"Growth hormone synthesis, secretion and action",17/253,122/8535,9.77E-08,4.59E-07,1.82E-07,EP300/CREBBP/PIK3CA/HRAS/AKT1/KRAS/SOS1/MTOR/MAP3K1/PLCG1/PTK2/PIK3R1/GRB2/STAT3/MAPK1/RAF1/JAK2,17
hsa04659,Th17 cell differentiation,16/253,109/8535,1.12E-07,5.17E-07,2.06E-07,RXRA/HSP90AB1/JUN/HSP90AA1/MTOR/SMAD4/PLCG1/IKBKB/TGFBR2/STAT3/LCK/MAPK1/NFKBIA/JAK2/SMAD3/TGFBR1,16
hsa04910,Insulin signaling pathway,18/253,138/8535,1.15E-07,5.18E-07,2.06E-07,PIK3CA/HRAS/AKT1/TSC1/KRAS/SOS1/MTOR/PIK3R1/IKBKB/GRB2/INPPL1/INSR/MAPK1/RAF1/CBL/BRAF/ACACA/TSC2,18
hsa04917,Prolactin signaling pathway,13/253,71/8535,1.26E-07,5.60E-07,2.22E-07,PIK3CA/HRAS/AKT1/KRAS/SOS1/SRC/PIK3R1/GRB2/STAT3/MAPK1/ESR1/RAF1/JAK2,13
hsa04915,Estrogen signaling pathway,18/253,139/8535,1.28E-07,5.60E-07,2.22E-07,PIK3CA/HRAS/HSP90AB1/JUN/AKT1/KRAS/HSP90AA1/HSPA8/SOS1/SRC/EGFR/PIK3R1/GRB2/MAPK1/ESR1/NCOA3/RAF1/HSPA1L,18
hsa04370,VEGF signaling pathway,12/253,60/8535,1.40E-07,6.02E-07,2.39E-07,PIK3CA/HRAS/AKT1/KRAS/CDC42/SRC/PLCG1/PTK2/PIK3R1/MAPK1/RAF1/KDR,12
hsa05418,Fluid shear stress and atherosclerosis,18/253,141/8535,1.60E-07,6.74E-07,2.68E-07,TP53/PIK3CA/ACTB/RHOA/HSP90AB1/JUN/AKT1/HSP90AA1/SRC/ACTG1/PTK2/PIK3R1/NFE2L2/IKBKB/CTNNB1/MAP3K5/ITGAV/KDR,18
hsa03082,ATP-dependent chromatin remodeling,16/253,117/8535,3.06E-07,1.27E-06,5.05E-07,ARID1A/ACTB/HDAC1/SMARCA4/CHD4/TRRAP/ACTG1/CHD3/EP400/ARID2/SMARCC2/BPTF/SMARCA2/INO80/SRCAP/ARID1B,16
hsa04820,Cytoskeleton in muscle cells,23/253,232/8535,3.37E-07,1.37E-06,5.46E-07,SPTAN1/ACTB/TTN/PLEC/DMD/FN1/SYNE1/MYH9/ACTG1/NEB/HSPG2/ANK2/OBSCN/DSP/ANK3/SPTBN1/VCAN/SYNE2/MYH10/XIRP2/ITGAV/LMNA/COL6A3,23
hsa05132,Salmonella infection,24/253,251/8535,3.62E-07,1.45E-06,5.78E-07,PIK3CA/ACTB/RHOA/HRAS/HSP90AB1/JUN/AKT1/FLNA/HSP90AA1/CDC42/ACTG1/IKBKB/CTNNB1/DYNC1H1/AHNAK/RHOB/CASP8/MAPK1/AHNAK2/PTPRC/RAF1/NFKBIA/DNM2/DCTN1,24
hsa04662,B cell receptor signaling pathway,14/253,91/8535,3.93E-07,1.55E-06,6.18E-07,PIK3CA/HRAS/JUN/AKT1/KRAS/SYK/SOS1/PIK3R1/IKBKB/GRB2/INPPL1/MAPK1/RAF1/NFKBIA,14
hsa04625,C-type lectin receptor signaling pathway,15/253,105/8535,4.06E-07,1.58E-06,6.28E-07,PIK3CA/RHOA/HRAS/JUN/AKT1/KRAS/SYK/SRC/PIK3R1/IKBKB/CASP8/MAPK1/RAF1/NFKBIA/MDM2,15
hsa05135,Yersinia infection,17/253,138/8535,5.98E-07,2.29E-06,9.10E-07,PIK3CA/ACTB/RHOA/JUN/AKT1/FN1/CDC42/SRC/ACTG1/PLCG1/PTK2/PIK3R1/IKBKB/LCK/MAPK1/NFKBIA/TBK1,17
hsa04664,Fc epsilon RI signaling pathway,12/253,69/8535,6.97E-07,2.63E-06,1.04E-06,PIK3CA/HRAS/AKT1/KRAS/SYK/SOS1/FYN/PLCG1/PIK3R1/GRB2/MAPK1/RAF1,12
hsa04066,HIF-1 signaling pathway,15/253,110/8535,7.52E-07,2.79E-06,1.11E-06,EP300/CREBBP/PIK3CA/ERBB2/CDKN1A/AKT1/EGFR/MTOR/PLCG1/PIK3R1/STAT3/INSR/MAPK1/IGF1R/ARNT,15
hsa04150,mTOR signaling pathway,18/253,158/8535,8.96E-07,3.27E-06,1.30E-06,PIK3CA/RHOA/HRAS/AKT1/TSC1/KRAS/PTEN/SOS1/MTOR/PIK3R1/IKBKB/GRB2/INSR/MAPK1/RAF1/IGF1R/BRAF/TSC2,18
hsa05208,Chemical carcinogenesis - reactive oxygen species,22/253,227/8535,9.05E-07,3.27E-06,1.30E-06,PIK3CA/HRAS/JUN/AKT1/KRAS/ABL1/PTEN/SOS1/SRC/EGFR/PTK2/PIK3R1/NFE2L2/IKBKB/GRB2/MET/MAPK1/RAF1/NFKBIA/MAP3K5/BRAF/ARNT,22
hsa04062,Chemokine signaling pathway,20/253,193/8535,1.01E-06,3.59E-06,1.43E-06,PIK3CA/RHOA/HRAS/AKT1/KRAS/CDC42/SOS1/SRC/PLCG1/PTK2/PIK3R1/IKBKB/GRB2/STAT3/MAPK1/RAF1/NFKBIA/JAK2/PARD3/BRAF,20
hsa04550,Signaling pathways regulating pluripotency of stem cells,17/253,144/8535,1.10E-06,3.86E-06,1.53E-06,PIK3CA/APC/FGFR3/HRAS/AKT1/KRAS/SMAD4/PIK3R1/CTNNB1/GRB2/STAT3/MAPK1/RAF1/JAK2/IGF1R/KAT6A/SMAD3,17
hsa04213,Longevity regulating pathway - multiple species,11/253,62/8535,1.67E-06,5.76E-06,2.29E-06,PIK3CA/HDAC1/HRAS/AKT1/KRAS/HSPA8/MTOR/PIK3R1/INSR/IGF1R/HSPA1L,11
hsa05168,Herpes simplex virus 1 infection,19/253,182/8535,1.70E-06,5.80E-06,2.30E-06,TP53/PIK3CA/AKT1/TSC1/SYK/SRC/MTOR/PIK3R1/IKBKB/CASP8/PML/ALYREF/NFKBIA/JAK2/HLA-B/TBK1/C3/TSC2/DAXX,19
hsa04360,Axon guidance,19/253,184/8535,2.00E-06,6.75E-06,2.68E-06,PIK3CA/RHOA/HRAS/KRAS/ABL1/CDC42/FYN/SRC/PLCG1/PTK2/PIK3R1/DCC/EPHA2/MET/MAPK1/RAF1/PARD3/RASA1/PTCH1,19
hsa04211,Longevity regulating pathway,13/253,90/8535,2.16E-06,7.16E-06,2.85E-06,TP53/PIK3CA/HRAS/AKT1/TSC1/KRAS/PPARG/MTOR/PIK3R1/INSR/IGF1R/RB1CC1/TSC2,13
hsa05164,Influenza A,18/253,173/8535,3.37E-06,1.10E-05,4.39E-06,EP300/CREBBP/PIK3CA/ACTB/AKT1/ACTG1/PIK3R1/IKBKB/CASP8/PML/MAPK1/NUP98/RAF1/NFKBIA/JAK2/CDK6/TBK1/CDK4,18
hsa05131,Shigellosis,22/253,250/8535,4.54E-06,1.47E-05,5.83E-06,TP53/PIK3CA/ATM/ACTB/RHOA/CUL1/JUN/AKT1/CDC42/SRC/ACTG1/EGFR/MTOR/PLCG1/PTK2/PIK3R1/IKBKB/MAPK1/NFKBIA/MDM2/TBK1/C3,22
hsa05170,Human immunodeficiency virus 1 infection,20/253,213/8535,4.71E-06,1.50E-05,5.97E-06,PIK3CA/ATM/CUL1/HRAS/JUN/AKT1/KRAS/ATR/MTOR/PLCG1/PTK2/PIK3R1/IKBKB/CASP8/MAPK1/RAF1/NFKBIA/HLA-B/TBK1/AP1B1,20
hsa04926,Relaxin signaling pathway,15/253,130/8535,6.36E-06,2.01E-05,7.97E-06,PIK3CA/HRAS/JUN/AKT1/KRAS/SOS1/SRC/EGFR/PIK3R1/GRB2/TGFBR2/MAPK1/RAF1/NFKBIA/TGFBR1,15
hsa04115,p53 signaling pathway,11/253,75/8535,1.14E-05,3.55E-05,1.41E-05,TP53/ATM/CDKN1A/CDKN2A/ATR/PTEN/CASP8/MDM2/CDK6/CDK4/TSC2,11
hsa05162,Measles,15/253,139/8535,1.45E-05,4.45E-05,1.77E-05,TP53/PIK3CA/JUN/AKT1/HSPA8/CSNK2A1/PIK3R1/IKBKB/CASP8/STAT3/NFKBIA/CDK6/HSPA1L/TBK1/CDK4,15
hsa04350,TGF-beta signaling pathway,13/253,108/8535,1.68E-05,5.10E-05,2.03E-05,EP300/CREBBP/RHOA/CUL1/HDAC1/NCOR1/SMAD4/PPP2R1A/TGFBR2/MAPK1/SIN3A/SMAD3/TGFBR1,13
hsa04144,Endocytosis,21/253,252/8535,1.74E-05,5.23E-05,2.08E-05,RHOA/FGFR3/CLTC/HRAS/CDC42/HSPA8/SRC/EGFR/TGFBR2/EPS15/PML/PDGFRA/MDM2/HLA-B/PARD3/IGF1R/DNM2/CBL/HSPA1L/SMAD3/TGFBR1,21
hsa05202,Transcriptional misregulation in cancer,18/253,198/8535,2.22E-05,6.58E-05,2.61E-05,TP53/ATM/CDKN1A/KDM6A/HDAC1/RXRA/NCOR1/DDX5/KMT2A/PPARG/PTK2/TGFBR2/MET/PML/FUS/MDM2/IGF1R/SIN3A,18
hsa04140,Autophagy - animal,16/253,169/8535,3.90E-05,0.000114145,4.54E-05,PIK3CA/HRAS/AKT1/TSC1/KRAS/PTEN/MTOR/PIK3R1/BIRC6/MAPK1/RAF1/IGF1R/TBK1/WDFY3/RB1CC1/TSC2,16
hsa04650,Natural killer cell mediated cytotoxicity,14/253,134/8535,4.04E-05,0.000116866,4.64E-05,PIK3CA/HRAS/KRAS/SYK/SOS1/FYN/PLCG1/PIK3R1/GRB2/LCK/MAPK1/RAF1/HLA-B/BRAF,14
hsa05142,Chagas disease,12/253,103/8535,4.94E-05,0.000141434,5.62E-05,PIK3CA/JUN/AKT1/PIK3R1/IKBKB/PPP2R1A/TGFBR2/CASP8/MAPK1/NFKBIA/C3/TGFBR1,12
hsa04730,Long-term depression,9/253,60/8535,6.04E-05,0.00016964,6.74E-05,HRAS/KRAS/RYR1/CACNA1A/PPP2R1A/MAPK1/RAF1/IGF1R/BRAF,9
hsa04390,Hippo signaling pathway,15/253,157/8535,6.13E-05,0.00016964,6.74E-05,ACTB/APC/ACTG1/SMAD4/CTNNB1/PPP2R1A/CSNK1E/TGFBR2/PARD3/YWHAZ/TP53BP2/CDH1/SMAD3/LATS1/TGFBR1,15
hsa04071,Sphingolipid signaling pathway,13/253,122/8535,6.20E-05,0.00016964,6.74E-05,TP53/PIK3CA/RHOA/HRAS/AKT1/KRAS/PTEN/FYN/PIK3R1/PPP2R1A/MAPK1/RAF1/MAP3K5,13
hsa04152,AMPK signaling pathway,13/253,122/8535,6.20E-05,0.00016964,6.74E-05,PIK3CA/AKT1/TSC1/PPARG/MTOR/PIK3R1/PPP2R1A/INSR/EEF2/IGF1R/ACACA/CFTR/TSC2,13
hsa04380,Osteoclast differentiation,14/253,143/8535,8.28E-05,0.000224047,8.90E-05,PIK3CA/JUN/AKT1/SYK/FYN/PPARG/PIK3R1/IKBKB/GRB2/TGFBR2/LCK/MAPK1/NFKBIA/TGFBR1,14
hsa04912,GnRH signaling pathway,11/253,93/8535,8.87E-05,0.000237538,9.44E-05,HRAS/JUN/KRAS/CDC42/SOS1/SRC/EGFR/MAP3K1/GRB2/MAPK1/RAF1,11
hsa04914,Progesterone-mediated oocyte maturation,12/253,111/8535,0.000103316,0.000273678,0.000108754,PIK3CA/HSP90AB1/AKT1/KRAS/HSP90AA1/PLK1/PIK3R1/MAPK1/RAF1/IGF1R/BRAF/CDC27,12
hsa04630,JAK-STAT signaling pathway,15/253,168/8535,0.000132616,0.000347594,0.000138127,EP300/CREBBP/PIK3CA/CDKN1A/HRAS/AKT1/SOS1/EGFR/MTOR/PIK3R1/GRB2/STAT3/PDGFRA/RAF1/JAK2,15
hsa04530,Tight junction,15/253,170/8535,0.000151401,0.000392696,0.000156049,ERBB2/ACTB/RHOA/JUN/MYH9/CDC42/SRC/ACTG1/MAP3K1/PPP2R1A/PARD3/MAP3K5/MYH10/CDK4/CFTR,15
hsa04666,Fc gamma R-mediated phagocytosis,11/253,99/8535,0.000156839,0.000402608,0.000159988,PIK3CA/AKT1/SYK/CDC42/PLCG1/PIK3R1/INPPL1/MAPK1/PTPRC/RAF1/DNM2,11
hsa04921,Oxytocin signaling pathway,14/253,155/8535,0.000196436,0.000499109,0.000198335,ACTB/CDKN1A/RHOA/HRAS/JUN/KRAS/SRC/ACTG1/EGFR/RYR2/RYR1/MAPK1/EEF2/RAF1,14
hsa04371,Apelin signaling pathway,13/253,140/8535,0.000252297,0.000634566,0.000252163,HRAS/AKT1/KRAS/MTOR/SMAD4/RYR2/RYR1/MAPK1/RAF1/CDH1/SMAD3/NOTCH3/TGFBR1,13
hsa04930,Type II diabetes mellitus,7/253,47/8535,0.000422231,0.001051356,0.000417787,PIK3CA/MTOR/PIK3R1/IKBKB/CACNA1A/INSR/MAPK1,7
hsa04714,Thermogenesis,17/253,235/8535,0.000600405,0.001480207,0.000588203,ARID1A/ACTB/HRAS/TSC1/KRAS/SMARCA4/SOS1/ACTG1/PPARG/MTOR/GRB2/SMARCC2/KDM1A/SMARCA2/MAP3K5/ARID1B/TSC2,17
hsa04934,Cushing syndrome,13/253,155/8535,0.000676667,0.001651865,0.000656416,KMT2D/CDKN1A/APC/RB1/CDKN2A/KMT2A/EGFR/CTNNB1/MAPK1/CDK6/BRAF/CDK4/ARNT,13
hsa05412,Arrhythmogenic right ventricular cardiomyopathy,9/253,86/8535,0.000961817,0.00232517,0.000923974,ACTB/DMD/ACTG1/RYR2/DSP/CTNNB1/CDH2/ITGAV/LMNA,9
hsa04120,Ubiquitin mediated proteolysis,12/253,142/8535,0.001012862,0.002425026,0.000963654,CUL1/HUWE1/BRCA1/FBXW7/HERC2/MAP3K1/BIRC6/UBR5/PML/MDM2/CBL/CDC27,12
hsa05120,Epithelial cell signaling in Helicobacter pylori infection,8/253,71/8535,0.001129667,0.002678924,0.001064548,JUN/CDC42/SRC/EGFR/PLCG1/IKBKB/MET/NFKBIA,8
hsa04540,Gap junction,9/253,92/8535,0.001557909,0.003659618,0.001454255,HRAS/KRAS/SOS1/SRC/EGFR/GRB2/MAPK1/PDGFRA/RAF1,9
hsa04658,Th1 and Th2 cell differentiation,9/253,93/8535,0.0016812,0.003912326,0.001554676,JUN/PLCG1/IKBKB/LCK/MAPK1/NOTCH1/NFKBIA/JAK2/NOTCH3,9
hsa05145,Toxoplasmosis,10/253,112/8535,0.001745241,0.00402375,0.001598954,AKT1/HSPA8/IKBKB/CASP8/STAT3/MAPK1/NFKBIA/JAK2/HSPA1L/LAMA4,10
hsa04310,Wnt signaling pathway,13/253,174/8535,0.001959776,0.004446597,0.001766984,TP53/EP300/CREBBP/APC/RHOA/CUL1/JUN/CSNK2A1/SMAD4/CTNNB1/CSNK1E/CSNK1A1/SMAD3,13
hsa03040,Spliceosome,15/253,217/8535,0.00196436,0.004446597,0.001766984,SF3B1/HNRNPU/SF3B3/DDX5/HSPA8/U2AF2/PRPF3/ALYREF/SNRNP200/FUS/HNRNPK/PCBP1/DHX15/HSPA1L/EFTUD2,15
hsa04330,Notch signaling pathway,7/253,62/8535,0.002264877,0.005044493,0.002004576,EP300/CREBBP/HDAC1/NOTCH1/NCOR2/NOTCH3/SPEN,7
hsa04670,Leukocyte transendothelial migration,10/253,116/8535,0.002269009,0.005044493,0.002004576,PIK3CA/ACTB/RHOA/CDC42/ACTG1/PLCG1/PTK2/PIK3R1/CTNNB1/CTNND1,10
hsa05130,Pathogenic Escherichia coli infection,14/253,203/8535,0.002811963,0.006196273,0.002462269,ACTB/RHOA/JUN/ABL1/MYH9/CDC42/FYN/SRC/ACTG1/IKBKB/CASP8/MAPK1/NFKBIA/MYH10,14
hsa05010,Alzheimer disease,22/253,391/8535,0.002845235,0.006214591,0.002469548,PIK3CA/APC/HRAS/AKT1/KRAS/LRP1/CSNK2A1/MTOR/PIK3R1/IKBKB/CTNNB1/CSNK1E/CASP8/CSNK1A1/INSR/MAPK1/RAF1/MAP3K5/PSMC3/BRAF/PSMD2/RB1CC1,22
hsa04929,GnRH secretion,7/253,65/8535,0.002974239,0.006439875,0.002559071,PIK3CA/HRAS/AKT1/KRAS/PIK3R1/MAPK1/RAF1,7
hsa04720,Long-term potentiation,7/253,67/8535,0.003534068,0.007586061,0.003014541,EP300/CREBBP/HRAS/KRAS/MAPK1/RAF1/BRAF,7
hsa04611,Platelet activation,10/253,126/8535,0.004142796,0.00881672,0.003503579,PIK3CA/ACTB/RHOA/AKT1/SYK/FYN/SRC/ACTG1/PIK3R1/MAPK1,10
hsa04920,Adipocytokine signaling pathway,7/253,70/8535,0.004519933,0.009392703,0.003732463,RXRA/AKT1/MTOR/IKBKB/STAT3/NFKBIA/JAK2,7
hsa05416,Viral myocarditis,7/253,70/8535,0.004519933,0.009392703,0.003732463,ACTB/DMD/ABL1/FYN/ACTG1/CASP8/HLA-B,7
hsa05022,Pathways of neurodegeneration - multiple diseases,25/253,483/8535,0.004526604,0.009392703,0.003732463,APC/HRAS/KRAS/CSNK2A1/MTOR/PLCG1/RYR2/RYR1/CTNNB1/LRRK2/CSNK1E/HTT/CASP8/CSNK1A1/MAPK1/RAF1/FUS/MAP3K5/PSMC3/BRAF/TBK1/PSMD2/DCTN1/RB1CC1/DAXX,25
hsa05171,Coronavirus disease - COVID-19,15/253,238/8535,0.004727608,0.009728715,0.003865987,PIK3CA/JUN/SYK/EGFR/PLCG1/PIK3R1/IKBKB/RPL10/RPS2/STAT3/MAPK1/NFKBIA/TBK1/C3/RPS3A,15
hsa04613,Neutrophil extracellular trap formation,13/253,193/8535,0.004806741,0.009810481,0.003898479,PIK3CA/ACTB/HDAC1/AKT1/SYK/SRC/ACTG1/MTOR/PLCG1/PIK3R1/MAPK1/RAF1/C3,13
hsa04620,Toll-like receptor signaling pathway,9/253,109/8535,0.004951154,0.009884727,0.003927983,PIK3CA/JUN/AKT1/PIK3R1/IKBKB/CASP8/MAPK1/NFKBIA/TBK1,9
hsa04931,Insulin resistance,9/253,109/8535,0.004951154,0.009884727,0.003927983,PIK3CA/AKT1/PTEN/MTOR/PIK3R1/IKBKB/STAT3/INSR/NFKBIA,9
hsa04960,Aldosterone-regulated sodium reabsorption,5/253,38/8535,0.004962212,0.009884727,0.003927983,PIK3CA/KRAS/PIK3R1/INSR/MAPK1,5
hsa03460,Fanconi anemia pathway,6/253,55/8535,0.005493168,0.010855546,0.004313766,BRCA1/ATR/BRCA2/FANCA/MLH1/FANCD2,6
hsa05134,Legionellosis,6/253,56/8535,0.006003368,0.011770383,0.004677303,HSPA8/EEF1A1/CASP8/NFKBIA/HSPA1L/C3,6
hsa04932,Non-alcoholic fatty liver disease,11/253,157/8535,0.006904375,0.013431167,0.005337264,PIK3CA/RXRA/JUN/AKT1/CDC42/PPARG/PIK3R1/IKBKB/CASP8/INSR/MAP3K5,11
hsa04657,IL-17 signaling pathway,8/253,95/8535,0.007030347,0.013570204,0.005392514,HSP90AB1/JUN/HSP90AA1/IKBKB/CASP8/MAPK1/NFKBIA/TBK1,8
hsa04024,cAMP signaling pathway,14/253,226/8535,0.00725782,0.013901517,0.005524171,EP300/CREBBP/PIK3CA/RHOA/JUN/AKT1/RYR2/PIK3R1/MAPK1/RAF1/NFKBIA/BRAF/CFTR/PTCH1,14
hsa04725,Cholinergic synapse,9/253,116/8535,0.007408034,0.014080919,0.005595461,PIK3CA/HRAS/AKT1/KRAS/FYN/PIK3R1/CACNA1A/MAPK1/JAK2,9
hsa04114,Oocyte meiosis,10/253,139/8535,0.008205457,0.015478476,0.006150821,CUL1/SMC1A/PLK1/AR/SMC3/PPP2R1A/MAPK1/IGF1R/YWHAZ/CDC27,10
hsa04668,TNF signaling pathway,9/253,119/8535,0.008708763,0.016304376,0.006479016,PIK3CA/JUN/AKT1/PIK3R1/IKBKB/CASP8/MAPK1/NFKBIA/MAP3K5,9
hsa04916,Melanogenesis,8/253,101/8535,0.010050779,0.018676448,0.007421628,EP300/CREBBP/HRAS/KRAS/KIT/CTNNB1/MAPK1/RAF1,8
hsa05017,Spinocerebellar ataxia,10/253,144/8535,0.010401905,0.019185736,0.007624009,PIK3CA/AKT1/MTOR/PIK3R1/RYR1/CACNA1A/MAP3K5/PSMC3/PSMD2/RB1CC1,10
hsa04064,NF-kappa B signaling pathway,8/253,105/8535,0.012541201,0.022793861,0.009057802,ATM/SYK/CSNK2A1/PLCG1/IKBKB/LCK/NFKBIA/PARP1,8
hsa04137,Mitophagy - animal,8/253,105/8535,0.012541201,0.022793861,0.009057802,TP53/HUWE1/HRAS/JUN/KRAS/CSNK2A1/SRC/TBK1,8
hsa05152,Tuberculosis,11/253,182/8535,0.019390866,0.034987867,0.013903443,EP300/CREBBP/RHOA/AKT1/SYK/SRC/CASP8/MAPK1/RAF1/JAK2/C3,11
hsa04622,RIG-I-like receptor signaling pathway,6/253,72/8535,0.019556252,0.035032422,0.013921149,MAP3K1/IKBKB/CASP8/NFKBIA/DDX3X/TBK1,6
hsa04928,"Parathyroid hormone synthesis, secretion and action",8/253,115/8535,0.020712176,0.036838085,0.014638681,CDKN1A/RHOA/RXRA/EGFR/WNK1/MAPK1/RAF1/BRAF,8
hsa05016,Huntington disease,16/253,311/8535,0.022449444,0.039644763,0.015753996,TP53/EP300/CREBBP/HDAC1/CLTC/PPARG/MTOR/HTT/CASP8/POLR2A/MAP3K5/SIN3A/PSMC3/PSMD2/DCTN1/RB1CC1,16
hsa04340,Hedgehog signaling pathway,5/253,56/8535,0.024599052,0.043134958,0.017140926,CUL1/LRP2/CSNK1E/CSNK1A1/PTCH1,5
hsa05014,Amyotrophic lateral sclerosis,18/253,371/8535,0.027050628,0.046989778,0.018672751,TP53/ACTB/TPR/ACTG1/MTOR/RANBP2/HNRNPA2B1/ALYREF/NUP98/FUS/MAP3K5/PSMC3/TBK1/PSMD2/ERBB4/DCTN1/RB1CC1/DAXX,18
hsa04936,Alcoholic liver disease,9/253,144/8535,0.027198637,0.046989778,0.018672751,AKT1/IKBKB/CTNNB1/CASP8/NFKBIA/MAP3K5/TBK1/ACACA/C3,9
hsa05410,Hypertrophic cardiomyopathy,7/253,99/8535,0.027363525,0.046989778,0.018672751,ACTB/TTN/DMD/ACTG1/RYR2/ITGAV/LMNA,7
hsa05140,Leishmaniasis,6/253,79/8535,0.029370464,0.049833485,0.01980278,JUN/EEF1A1/MAPK1/NFKBIA/JAK2/C3,6
hsa03430,Mismatch repair,3/253,23/8535,0.029419768,0.049833485,0.01980278,MSH2/MLH1/RFC4,3
